|
[1]
|
COLEMAN CM,FRIEMAN MB.Coronaviruses:important emerging human pathogens[J].J Virol,2014,88(10):5209. |
|
[2]
|
CHAN PK,CHAN MC.Tracing the SARS-coronavirus[J].J Thorac Dis,2013,5(Suppl 2):S118. |
|
[3]
|
Centers for Disease Control and Prevention(CDC).Update:Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus(MERS-CoV)——worldwide,2012-2013[J].MMWR,2013,62(23):480. |
|
[4]
|
RAJ VS,OSTERHAUS AD,FOUCHIER RA,et al.MERS:emergence of a novel human coronavirus[J].Curr Opin Virol,2014,5:58. |
|
[5]
|
World Health Organization.Middle East respiratory syndrome coronavirus(MERS-CoV)-Saudi Arabia[Internet].2015[updated 29 July 2015]. |
|
[6]
|
NOWOTNY N,KOLODZIEJEK J.Middle East respiratory syndrome coronavirus(MERS-CoV) in dromedary camels,Oman,2013[J].Euro Surveill,2014,19(16):20781. |
|
[7]
|
HUI DS,MEMISH ZA,ZUMLA A.Severe acute respiratory syndrome vs.the Middle East respiratory syndrome[J].Curr Opin Pulm Med,2014,20(3):233. |
|
[8]
|
RAJ VS,MOU H,SMITS SL,et al.Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC[J].Nature,2013,495(7440):251. |
|
[9]
|
LIM PL,LEE TH,ROWE EK.Middle East respiratory syndrome coronavirus(MERS CoV):update 2013[J].Curr Infect Dis Rep,2013,15(4):295. |
|
[10]
|
ASSIRI A,AL-TAWFIQ JA,AL-RABEEAH AA,et al.Epidemiological,demographic,and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia:a descriptive study[J].Lancet Infect Dis,2013,13(9):752. |
|
[11]
|
ZAKI AM,VAN BOHEEMEN S,BESTEBROER TM,et al.Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J].N Engl J Med,2012,367(19):1814. |
|
[12]
|
AL-TAWFIQ JA.Middle East respiratory syndrome-coronavirus infection:an overview[J].J Infect Public Health,2013,6(5):319. |
|
[13]
|
BIALEK SR,ALLEN D,ALVARADO-RAMY F,et al.First confirmed cases of Middle East respiratory syndrome coronavirus(MERS-CoV) infection in the United States,updated information on the epidemiology of MERS-CoV infection,and guidance for the public,clinicians,and public health authorities-May 2014[J].MMWR,2014,63(19):431. |
|
[14]
|
CUNHA BA.Influenza:historical aspects of epidemics and pandemics[J].Infect Dis Clin North Am,2004,18(1):141. |
|
[15]
|
CUNHA BA.Swine Influenza(H1N1) pneumonia:clinical considerations[J].Infect Dis Clin North Am,2010,24(1):203. |
|
[16]
|
ZUMLA AI,MEMISH ZA.Middle East respiratory syndrome coronavirus:epidemic potential or a storm in a teacupy?[J].Eur Respir J,2014,43(5):1243. |
|
[17]
|
BREBAN R,RIOU J,FONTANET A.Inter-human transmissibility of Middle East respiratory syndrome coronavirus:estimation of pandemic risk[J].Lancet,2013,382(9893):694. |
|
[18]
|
MEMISH ZA,ZUMLAA,AL-TAWFIQ JA.How great is the risk of Middle East respiratory syndrome coronavirus to the global population?[J].Expert Rev Anti Infect Ther,2013,11(10):979. |
|
[19]
|
GAO HN,LU HZ,CAO B,et al.Clinical findings in 111 cases of influenza A(H7N9) virus infection[J].N Engl J Med,2013,368(24):2277. |
|
[20]
|
CUNAH CB,OPAL SM.Middle East respiratory syndrome (MERS) A new zoonotic viral pneumonia[J].Virulence,2014,5(6):650. |
|
[21]
|
WU J,YI L,ZOU L,et al.Imported case of MERS-CoV infection identified in China,May 2015:detection and lesson learned[J].Euro Surveill,2015,20(24):21158. |
|
[22]
|
ARABI YM,ARIFI AA,BALKHY HH,et al.Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection[J].Ann Intern Med,2014,160(6):389. |
|
[23]
|
DROSTEN C,SEILMAIER M,CORMAN VM,et al.Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection[J].Lancet Infect Dis,2013,13(9):745. |
|
[24]
|
OMRANI AS,MATIN MA,HADDAD Q,et al.A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case[J].Int J Infect Dis,2013,17(9):e668. |
|
[25]
|
ASSIRI A,AL-TAWFIQ JA,AL-RABEEAH AA,et al.Epidemiological,demographic,and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia:a descriptive study[J].Lancet Infect Dis,2013,13(9):752. |
|
[26]
|
GUERY B,POISSY J,EL MANSOUF L,et al.Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus:a report of nosocomial transmission[J].Lancet,2013,381(9885):2265. |
|
[27]
|
BERMINGHAM A,CHAND MA,BROWN CS,et al.Severe respiratory illness caused by a novel coronavirus,in a patient transferred to the United Kingdom from the Middle East,September 2012[J].Euro Surveill,2012,17(40):20290. |
|
[28]
|
WHO Mers-COV Research Group.State of knowledge and data gaps of Middle East respiratory syndrome coronavirus(MERS-CoV) in humans[J].PLoS Curr,2013,5. |
|
[29]
|
ZIELECKI F,WEBER M,EICKMANN M,et al.Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus[J].J Virol,2013,87(9):5300. |
|
[30]
|
CHAN RW,CHAN MC,AGNIHOTHRAM S,et al.Tropism of and innate immune responses to the novel human beta-coronavirus lineage C virus in human ex vivo respiratory organ cultures[J].J Virol,2013,87(12):6604. |
|
[31]
|
FALZARANO D,DE WIT E,RASMUSSEN AL,et al.Treatment with interferon-α 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques[J].Nat Med,2013,19(10):1313. |
|
[32]
|
AL-TAWFIQ JA,MOMATTIN H,DIB J,et al.Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus:an observational study[J].Int J Infect Dis,2014,20:42. |
|
[33]
|
LU L,LIU Q,ZHU Y,et al.Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor[J].Nat Commun,2014,5:3067. |
|
[34]
|
JIANG L,WANG N,ZUO T,et al.Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein[J].Sci Transl Med,2014,6(234):234ra59. |
|
[35]
|
ISARIC PHE.Treatment of MERS-CoV:Information for clinicians.Clinical decision-making support for treatment of MERS-CoV[R].https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/360424/MERS_COV_information_for_clinicians_17_July.pdf(accessed April 13,2015). |
|
[36]
|
YING T,DU L,JU TW,et al.Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies[J].J Virol,2014,88(14):7796. |
|
[37]
|
TANG XC,AGNIHOTHRAM SS,JIAO Y,et al.Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution[J].Proc Natl Acad Sci,2014,111(19):E2018. |
|
[38]
|
SONG F,FUX R,PROVACIA LB,et al.Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies[J].J Virol,2013,87(21):11950. |
|
[39]
|
COLEMAN CM,LIU YV,MU H,et al.Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice[J].Vaccine,2014,32(26):3169. |
|
[40]
|
MAILLES A,BLANCKAERT K,CHAUD P,et al.First cases of Middle East Respiratory Syndrome Coronavirus(MERS-CoV) infections in France,investigations and implications for the prevention of human-to-human transmission,France,May 2013[J].Euro Surveill,2013,18(24):20502. |
|
[41]
|
MOMATTIN H,MOHAMMED K,ZUMLA A,et al.Therapeutic options for Middle East respiratory syndrome coronavirus(MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy[J].Int J Infect Dis,2013,17(10):e792. |
|
[42]
|
ASSIRI A,MCGEER A,PERL TM,et al.Hospital outbreak of Middle East respiratory syndrome coronavirus[J].N Engl J Med,2013,369(5):407. |
|
[43]
|
HARRIMAN K,BROSSEAU L,TRIVEDI K.Hospital-associated Middle East respiratory syndrome coronavirus infections[J].N Engl J Med,2013,369:1761. |
|
[44]
|
ELACHOLA H,ASSIRI AM,MEMISH ZA.Mass gathering-related mask use during 2009 pandemic influenza A(H1N1) and Middle East respiratory syndrome coronavirus[J].Int J Infect Dis,2014,20:77. |
|
[45]
|
MEMISH ZA,ZUMLA AI,ASSIRI A.Middle East respiratory syndrome coronavirus infections in health care workers[J].N Engl J Med,2013,369(9):884. |
点击查看大图
下载:
